Atlantic Union Bankshares’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.7M Buy
132,010
+1,245
+1% +$276K 0.55% 42
2025
Q4
$29.9M Sell
130,765
-2,663
-2% -$607K 0.56% 41
2025
Q3
$30.9M Buy
133,428
+466
+0.4% +$94.9K 0.58% 36
2025
Q2
$24.7M Buy
132,962
+26,845
+25% +$4.99M 0.56% 43
2025
Q1
$22.2M Sell
106,117
-469
-0.4% -$91.2K 1.35% 14
2024
Q4
$18.9M Buy
106,586
+11,474
+12% +$2.11M 1.1% 16
2024
Q3
$18.8M Sell
95,112
-186
-0.2% -$34.7K 1.09% 17
2024
Q2
$16.3M Buy
95,298
+62,569
+191% +$10.4M 1.02% 21
2024
Q1
$5.96M Sell
32,729
-439
-1% -$75.7K 0.5% 55
2023
Q4
$5.14M Sell
33,168
-1,437
-4% -$210K 0.48% 58
2023
Q3
$5.16M Sell
34,605
-404
-1% -$59.3K 0.53% 52
2023
Q2
$4.72M Sell
35,009
-2,625
-7% -$385K 0.47% 61
2023
Q1
$6M Sell
37,634
-1,862
-5% -$285K 0.62% 47
2022
Q4
$6.38M Sell
39,496
-3,110
-7% -$477K 0.68% 45
2022
Q3
$5.72M Sell
42,606
-5,167
-11% -$741K 0.66% 47
2022
Q2
$7.32M Sell
47,773
-718
-1% -$110K 0.75% 42
2022
Q1
$7.86M Sell
48,491
-16,583
-25% -$2.41M 0.69% 47
2021
Q4
$8.81M Sell
65,074
-2,003
-3% -$237K 0.75% 39
2021
Q3
$7.24M Sell
67,077
-842
-1% -$96.2K 0.68% 48
2021
Q2
$7.65M Sell
67,919
-841
-1% -$94.7K 0.74% 42
2021
Q1
$7.44M Sell
68,760
-1,489
-2% -$159K 0.76% 43
2020
Q4
$7.53M Sell
70,249
-2,801
-4% -$269K 0.78% 37
2020
Q3
$6.4M Sell
73,050
-1,235
-2% -$116K 0.74% 39
2020
Q2
$7.29M Buy
74,285
+4,065
+6% +$358K 0.91% 28
2020
Q1
$5.35M Sell
70,220
-4,094
-6% -$349K 0.78% 37
2019
Q4
$6.58M Buy
74,314
+2,457
+3% +$204K 0.84% 28
2019
Q3
$5.44M Sell
71,857
-7,244
-9% -$497K 0.73% 37
2019
Q2
$5.75M Buy
79,101
+64,797
+453% +$5.09M 0.77% 33
2019
Q1
$1.15M Buy
14,304
+35
+0.2% +$2.86K 0.32% 67
2018
Q4
$1.32M Sell
14,269
-95
-0.7% -$8.35K 0.43% 64
2018
Q3
$1.36M Sell
14,364
-914
-6% -$86.7K 0.41% 63
2018
Q2
$1.42M Sell
15,278
-354
-2% -$34.6K 0.46% 61
2018
Q1
$1.48M Sell
15,632
-32
-0.2% -$3.52K 0.46% 62
2017
Q4
$1.51M Buy
15,664
+100
+0.6% +$9.43K 0.47% 61
2017
Q3
$1.38M Sell
15,564
-243
-2% -$18.5K 0.47% 61
2017
Q2
$1.15K Sell
15,807
-762
-5% -$51.2K 0.4% 60
2017
Q1
$1.08K Sell
16,569
-225
-1% -$14.1K 0.39% 62
2016
Q4
$1.05M Hold
16,794
0.39% 64
2016
Q3
$1.06M Sell
16,794
-609
-3% -$39.4K 0.4% 66
2016
Q2
$1.08M Sell
17,403
-134
-0.8% -$8.16K 0.42% 66
2016
Q1
$1M Sell
17,537
-285
-2% -$15.9K 0.42% 68
2015
Q4
$1.06M Sell
17,822
-5,546
-24% -$319K 0.46% 68
2015
Q3
$1.27M Buy
23,368
+4,652
+25% +$303K 0.59% 63
2015
Q2
$1.26M Sell
18,716
-1,014
-5% -$66.2K 0.59% 66
2015
Q1
$1.16M Buy
19,730
+325
+2% +$19.6K 0.53% 65
2014
Q4
$1.27M Sell
19,405
-828
-4% -$52.2K 0.57% 64
2014
Q3
$1.17M Sell
20,233
-325
-2% -$18K 0.55% 63
2014
Q2
$1.16M Sell
20,558
-18,145
-47% -$952K 0.54% 66
2014
Q1
$1.82M Buy
+38,703
New +$1.96M 0.84% 52

Other funds holding ABBV

Atlantic Union Bankshares's ABBV Position: Q1 2026 in Review

Atlantic Union Bankshares increased its AbbVie (ABBV) stake by 0.95% in Q1 2026, buying an estimated $276K and bringing the position to 132,010 shares worth $28.7M. The position accounts for 0.55% of the portfolio, ranked #42.

Atlantic Union Bankshares first reported a position in ABBV in Q1 2014 and has held it in 49 quarters since. The position peaked at $30.9M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Atlantic Union Bankshares held 132,010 shares of AbbVie worth $28.7M as of Q1 2026.
  • Atlantic Union Bankshares bought 1,245 AbbVie shares in Q1 2026, an estimated $276K.
  • AbbVie made up 0.55% of Atlantic Union Bankshares's portfolio in Q1 2026, its #42 holding.
  • Atlantic Union Bankshares first reported a position in AbbVie in Q1 2014 and has held it in 49 quarters since.
  • Atlantic Union Bankshares's AbbVie position peaked at $30.9M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.